Two years of Covid: India sees rise in vaccination, decline in cases

India recorded nearly 350,000 cases during the third wave, however, deaths were muted, unlike in the US and Europe

coronavirus
Photo: PTI
Ishaan Gera
1 min read Last Updated : Mar 23 2022 | 11:49 PM IST
Two years ago, on March 24, the government imposed a lockdown to curb the spread of Covid-19 cases. Restrictions on movement combined with limited testing resources meant low infection levels in the few months of lockdown. But as the government eased restrictions and started testing more from May 31, cases began rising. In September 2020, India crossed the 100,000 daily Covid-19 cases mark. Deaths during the first wave crossed the 1,000 daily tally during the same period. On October 4, 2020, India had registered over 100,000 deaths.

The second wave was more devastating as India added another 200,000 deaths within 66 days from April 28, 2021. The daily death count during the second wave crossed 4,000. Cases during this wave peaked above 400,000. India recorded nearly 350,000 cases during the third wave, however, deaths were muted, unlike in the US and Europe. One reason for low deaths during the Omicron wave may be India's fast pace of vaccination. 84 per cent people above 18 years had received both doses till March 23, 2022. 


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story